Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2753 results

Sort By:

Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma

Study ID: NCT07191379
Start Date: 2026-01-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

50

Intervention / Treatment

The study intervention is self-administration of SC daratumumab by the patient, thereby changing the administration from an outpatient setting to a home setting.

Sponsor

Odense University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Autologous Adipose Derived Stromal Vascular Fraction for Musculoskeletal Conditions

Study ID: NCT06000670
Start Date: 2026-12-30
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

stromal vascular fraction injection in the osteoarthritic knee

Sponsor

Dubai Health Authority

Source: clinicaltrials.gov

Share:
Add to list

Portable Positive Pressure Therapy Device

Study ID: NCT04452851
Start Date: 2026-12-01
End Date: 2027-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

BREATHE

BiPAP

COPD Inhaler

Sponsor

Koronis Biomedical Technologies

Source: clinicaltrials.gov

Share:
Add to list

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry

Study ID: NCT05158751
Start Date: 2026-01
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

Kansas City Heart Rhythm Research Foundation

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment

Study ID: NCT07197801
Start Date: 2026-01-02
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

218

Intervention / Treatment

Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment

Sponsor

Geisinger Clinic

Source: clinicaltrials.gov

Share:
Add to list

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Study ID: NCT07148050
Start Date: 2025-12-15
End Date: 2044-04-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

21

Intervention / Treatment

SC-CAR.GPC3xIL15.21 CAR T cells

Sponsor

Seattle Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Ketamine for Opioid Use Disorder

Study ID: NCT06943859
Start Date: 2025-11-07
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Treatment with Ketamine

Treatment with Active Placebo

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

Study ID: NCT07015996
Start Date: 2026-02-18
End Date: 2028-09-16
Study Type

Interventional

Study Phase

Phase2

No. of Participants

62

Intervention / Treatment

Tezepelumab

Peanut Oral Immunotherapy (OIT)

Placebo for Tezepelumab

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

Putting Children First - Parent Training for Parents in High Conflict

Study ID: NCT06809153
Start Date: 2026-03-01
End Date: 2027-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

500

Intervention / Treatment

Putting Children First

Sponsor

IRIS Media Inc

Source: clinicaltrials.gov

Share:
Add to list

RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence

Study ID: NCT07202975
Start Date: 2027-01-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

314

Intervention / Treatment

Mixed realities rehabilitation program

Usual Care

Sponsor

Jaume I University

Source: clinicaltrials.gov

Share:
Add to list